The gut microbiome in neurological disorders

[1]  A. Hannan,et al.  Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease , 2020, Neurobiology of Disease.

[2]  Kieran Rea,et al.  The Microbiota-Gut-Brain Axis. , 2019, Physiological reviews.

[3]  Nikhil Panicker,et al.  Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease , 2019, Neuron.

[4]  J. Gilbert,et al.  Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes , 2019, The Journal of experimental medicine.

[5]  T. Dinan,et al.  Mid-life microbiota crises: middle age is associated with pervasive neuroimmune alterations that are reversed by targeting the gut microbiome , 2019, Molecular Psychiatry.

[6]  Young-Mo Kim,et al.  Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice , 2019, Cell.

[7]  Yan He,et al.  Stroke Dysbiosis Index (SDI) in Gut Microbiome Are Associated With Brain Injury and Prognosis of Stroke , 2019, Front. Neurol..

[8]  J. Caporaso,et al.  Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota , 2019, Scientific Reports.

[9]  C. Braun,et al.  Bifidobacterium longum 1714™ Strain Modulates Brain Activity of Healthy Volunteers During Social Stress , 2019, The American journal of gastroenterology.

[10]  B. Griffin,et al.  Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions , 2019, Pharmacological Reviews.

[11]  T. Dinan,et al.  Psychotropics and the Microbiome: a Chamber of Secrets… , 2019, Psychopharmacology.

[12]  E. Borenstein,et al.  The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy , 2019, npj Biofilms and Microbiomes.

[13]  Pingchang Yang,et al.  Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder , 2019, Scientific Reports.

[14]  A. Keshavarzian,et al.  Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease , 2019, Nature Communications.

[15]  R. Britton,et al.  Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder , 2019, Neuron.

[16]  T. Dinan,et al.  Programming Bugs: Microbiota and the Developmental Origins of Brain Health and Disease , 2019, Biological Psychiatry.

[17]  Andrew P. Salzwedel,et al.  Gut microbiome and brain functional connectivity in infants-a preliminary study focusing on the amygdala , 2019, Psychopharmacology.

[18]  Nicholas M. Vogt,et al.  The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease , 2018, Alzheimer's Research & Therapy.

[19]  Honglei Chen,et al.  The vermiform appendix impacts the risk of developing Parkinson’s disease , 2018, Science Translational Medicine.

[20]  F. Hu,et al.  Plasma concentration of trimethylamine-N-oxide and risk of gestational diabetes mellitus. , 2018, The American journal of clinical nutrition.

[21]  T. Dinan,et al.  Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function , 2018, Psychopharmacology.

[22]  T. Dinan,et al.  Short‐chain fatty acids: microbial metabolites that alleviate stress‐induced brain–gut axis alterations , 2018, The Journal of physiology.

[23]  D. Nielsen,et al.  A prebiotic intervention study in children with autism spectrum disorders (ASDs) , 2018, Microbiome.

[24]  H. Remaut,et al.  The Role of Functional Amyloids in Bacterial Virulence , 2018, Journal of molecular biology.

[25]  E. Hsiao,et al.  The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet , 2018, Cell.

[26]  G. Gloor,et al.  Metabolic products of the intestinal microbiome and extremes of atherosclerosis. , 2018, Atherosclerosis.

[27]  H. Weiner,et al.  A probiotic modulates the microbiome and immunity in multiple sclerosis , 2018, Annals of neurology.

[28]  J. Chudek,et al.  Toxin profile of fecal Clostridium perfringens strains isolated from children with autism spectrum disorders. , 2018, Anaerobe.

[29]  Huadong Zhou,et al.  Gut Microbiota is Altered in Patients with Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.

[30]  T. Dinan,et al.  Social interaction-induced activation of RNA splicing in the amygdala of microbiome-deficient mice , 2018, eLife.

[31]  J. Sun,et al.  Clostridium butyricum exerts a neuroprotective effect in a mouse model of traumatic brain injury via the gut‐brain axis , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[32]  Chun Cui,et al.  Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway , 2018, Brain, Behavior, and Immunity.

[33]  T. Dinan,et al.  Recent developments in understanding the role of the gut microbiota in brain health and disease , 2018, Annals of the New York Academy of Sciences.

[34]  Rob Knight,et al.  Current understanding of the human microbiome , 2018, Nature Medicine.

[35]  Peer Bork,et al.  Extensive impact of non-antibiotic drugs on human gut bacteria , 2018, Nature.

[36]  Jochen H Weishaupt,et al.  The fecal microbiome of ALS patients , 2018, Neurobiology of Aging.

[37]  D. J. Doty,et al.  Variations in diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model. , 2018, Beneficial microbes.

[38]  John H. Gilmore,et al.  Infant Gut Microbiome Associated With Cognitive Development , 2018, Biological Psychiatry.

[39]  T. Dinan,et al.  Gutsy Moves: The Amygdala as a Critical Node in Microbiota to Brain Signaling , 2018, BioEssays : news and reviews in molecular, cellular and developmental biology.

[40]  A. Heintz‐Buschart,et al.  The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder , 2017, Movement disorders : official journal of the Movement Disorder Society.

[41]  P. de Vos,et al.  Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice , 2017, Front. Immunol..

[42]  M. Sundman,et al.  The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease , 2017, Brain, Behavior, and Immunity.

[43]  Sterling C. Johnson,et al.  Gut microbiome alterations in Alzheimer’s disease , 2017, Scientific Reports.

[44]  M. Salami,et al.  Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. , 2017, Clinical nutrition.

[45]  T. Dinan,et al.  Revisiting Metchnikoff: Age-related alterations in microbiota-gut-brain axis in the mouse , 2017, Brain, Behavior, and Immunity.

[46]  C. Lowry,et al.  Growing literature but limited evidence: A systematic review regarding prebiotic and probiotic interventions for those with traumatic brain injury and/or posttraumatic stress disorder , 2017, Brain, Behavior, and Immunity.

[47]  Jennifer S. Labus,et al.  Brain Structure and Response to Emotional Stimuli as Related to Gut Microbial Profiles in Healthy Women , 2017, Psychosomatic medicine.

[48]  M. Salami,et al.  The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial , 2017, Journal of the American College of Nutrition.

[49]  Hyunju Kim,et al.  Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring , 2017, Nature.

[50]  K. Berer,et al.  Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice , 2017, Proceedings of the National Academy of Sciences.

[51]  Stephen L. Hauser,et al.  Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models , 2017, Proceedings of the National Academy of Sciences.

[52]  Chuangzhao Qiu,et al.  Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy , 2017, World journal of gastroenterology.

[53]  R. Tanzi,et al.  Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer’s disease , 2017, Scientific Reports.

[54]  J. Gunstad,et al.  Preliminary Evidence for an Association Between the Composition of the Gut Microbiome and Cognitive Function in Neurologically Healthy Older Adults , 2017, Journal of the International Neuropsychological Society.

[55]  T. Dinan,et al.  Microbiota regulates visceral pain in the mouse , 2017, eLife.

[56]  James T. Morton,et al.  Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome , 2017, Movement disorders : official journal of the Movement Disorder Society.

[57]  J. Walter,et al.  A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome , 2017, Microbiome.

[58]  Luis Pedro Coelho,et al.  Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients , 2017, Genome Medicine.

[59]  P. Svenningsson,et al.  Vagotomy and Parkinson disease , 2017, Neurology.

[60]  O. Koren,et al.  Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior , 2017, Nature Communications.

[61]  T. Dinan,et al.  Gut Feelings on Parkinson’s and Depression , 2017, Cerebrum : the Dana forum on brain science.

[62]  T. Dinan,et al.  Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice , 2017, Biological Psychiatry.

[63]  G. Frisoni,et al.  Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota , 2017, Scientific Reports.

[64]  Weili Zhang,et al.  Gut microbiota dysbiosis contributes to the development of hypertension , 2017, Microbiome.

[65]  G. Frisoni,et al.  Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly , 2017, Neurobiology of Aging.

[66]  T. Borody,et al.  Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study , 2017, Microbiome.

[67]  Harriët Schellekens,et al.  Feeding the microbiota‐gut‐brain axis: diet, microbiome, and neuropsychiatry , 2017, Translational research : the journal of laboratory and clinical medicine.

[68]  Hua Zhu,et al.  Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[69]  C. Adler,et al.  Does Parkinson’s disease start in the gut? , 2017, Acta Neuropathologica.

[70]  Rob Knight,et al.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease , 2016, Cell.

[71]  M. Salami,et al.  Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial , 2016, Front. Aging Neurosci..

[72]  K. Fassbender,et al.  Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. , 2016, Parkinsonism & related disorders.

[73]  G. Boylan,et al.  Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers , 2016, Translational psychiatry.

[74]  D. Brough,et al.  Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production , 2016, Brain, Behavior, and Immunity.

[75]  E. Cereda,et al.  Probiotics and prebiotic fiber for constipation associated with Parkinson disease , 2016, Neurology.

[76]  J. Rho,et al.  Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder , 2016, Molecular Autism.

[77]  Ali A. Faruqi,et al.  Gut microbiota in early pediatric multiple sclerosis: a case−control study , 2016, European journal of neurology.

[78]  M. Dichgans,et al.  Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke , 2016, The Journal of Neuroscience.

[79]  John F. Cryan,et al.  Adult microbiota‐deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus , 2016, The European journal of neuroscience.

[80]  Junjie Yu,et al.  Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota , 2016, Brain Research.

[81]  Laura M Cox,et al.  Alterations of the human gut microbiome in multiple sclerosis , 2016, Nature Communications.

[82]  Krishna R. Kalari,et al.  Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls , 2016, Scientific Reports.

[83]  Gonzalo Viana Di Prisco,et al.  Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring , 2016, Cell.

[84]  G. O’Keeffe,et al.  Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. , 2016, Parkinsonism & related disorders.

[85]  U. Dirnagl,et al.  Depletion of Cultivatable Gut Microbiota by Broad-Spectrum Antibiotic Pretreatment Worsens Outcome After Murine Stroke , 2016, Stroke.

[86]  Hugo Lövheim,et al.  Microbes and Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[87]  T. Dinan,et al.  Regulation of prefrontal cortex myelination by the microbiota , 2016, Translational Psychiatry.

[88]  T. Dinan,et al.  The microbiome: A key regulator of stress and neuroinflammation , 2016, Neurobiology of Stress.

[89]  Eric G. Pamer,et al.  Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδT cells , 2016, Nature Medicine.

[90]  T. Dinan,et al.  Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior , 2016, The international journal of neuropsychopharmacology.

[91]  R. Milo,et al.  Revised Estimates for the Number of Human and Bacteria Cells in the Body , 2016, bioRxiv.

[92]  K. Ohno,et al.  Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease , 2015, PloS one.

[93]  T. Dinan,et al.  Microbes & neurodevelopment – Absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala , 2015, Brain, Behavior, and Immunity.

[94]  Yan He,et al.  Dysbiosis of Gut Microbiota With Reduced Trimethylamine‐N‐Oxide Level in Patients With Large‐Artery Atherosclerotic Stroke or Transient Ischemic Attack , 2015, Journal of the American Heart Association.

[95]  E. Horváth-Puhó,et al.  Vagotomy and subsequent risk of Parkinson's disease , 2015, Annals of neurology.

[96]  M. Hattori,et al.  Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters , 2015, PloS one.

[97]  Ali Keshavarzian,et al.  Colonic bacterial composition in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[98]  T. Dinan,et al.  Adult Hippocampal Neurogenesis Is Regulated by the Microbiome , 2015, Biological Psychiatry.

[99]  A. Venkatesan,et al.  Gut Microbiota in Multiple Sclerosis , 2015, Journal of Investigative Medicine.

[100]  I. Amit,et al.  Host microbiota constantly control maturation and function of microglia in the CNS , 2015, Nature Neuroscience.

[101]  H. D. Rosas,et al.  A systems-level “misunderstanding”: the plasma metabolome in Huntington’s disease , 2015, Annals of clinical and translational neurology.

[102]  E. Chambers,et al.  The role of short chain fatty acids in appetite regulation and energy homeostasis , 2015, International Journal of Obesity.

[103]  E. Pekkonen,et al.  Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.

[104]  D. Ostatníková,et al.  Gastrointestinal microbiota in children with autism in Slovakia , 2015, Physiology & Behavior.

[105]  A. Russo.  Decreased Plasma Myeloperoxidase Associated with Probiotic Therapy in Autistic Children , 2015, Clinical medicine insights. Pediatrics.

[106]  R. Friedland.  Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. , 2015, Journal of Alzheimer's disease : JAD.

[107]  Lai Guan Ng,et al.  The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.

[108]  Jia-Yi Li,et al.  Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats , 2014, Acta Neuropathologica.

[109]  David Padua,et al.  Altered brain‐gut axis in autism: Comorbidity or causative mechanisms? , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.

[110]  P. Scully,et al.  Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats , 2014, Neuroscience.

[111]  Young-Chul Chung,et al.  Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults , 2014 .

[112]  T. Dinan,et al.  Microbiota and neurodevelopmental windows: implications for brain disorders. , 2014, Trends in molecular medicine.

[113]  L. Desbonnet,et al.  Microbiota is essential for social development in the mouse , 2013, Molecular Psychiatry.

[114]  C. Carroll,et al.  Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease , 2014, Acta Neuropathologica.

[115]  J. Petrosino,et al.  Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.

[116]  S. Collins,et al.  Gut microbiota: Intestinal bacteria influence brain activity in healthy humans , 2013, Nature Reviews Gastroenterology &Hepatology.

[117]  P. Scully,et al.  The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner , 2013, Molecular Psychiatry.

[118]  S. Hazen,et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.

[119]  D. Sinderen,et al.  Gut microbiota composition correlates with diet and health in the elderly , 2012, Nature.

[120]  Jeffrey H. Kordower,et al.  Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease , 2011, PloS one.

[121]  K. Berer,et al.  Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination , 2011, Nature.

[122]  B. Hyman,et al.  The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide , 2010, PloS one.

[123]  H. Braak,et al.  Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.

[124]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.